D&D Pharmatech Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $137M
Latest Deal Amount
  • Investors
  • 7

D&D Pharmatech General Information

Description

Operator of a clinical-stage biotech company designed to develop therapeutic products for patients. The company's specializes in the research and development of a range of indications including neurodegenerative, metabolic and fibrotic diseases to accelerate the research process into life-saving medicines for patients, enabling the healthcare industry to provide advanced medical attention for efficient treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 5th Floor, I&C Building, 24
  • Pangyo-ro 255 beon-gil, Bundang-gu
  • Seongnam-si, Gyeonggi-do 13486
  • South Korea

D&D Pharmatech Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

D&D Pharmatech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 14-Aug-2019 $137M 00000 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 01-May-2019 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Mar-2018 $16.6M $16.6M Completed Clinical Trials - Phase 2
To view D&D Pharmatech’s complete valuation and funding history, request access »

D&D Pharmatech Executive Team (4)

Name Title Board Seat Contact Info
Sung Mook Lim Chief Executive Officer
Kang Choon Lee Ph.D Co-Founder
Seulki Lee Ph.D Co-Founder
Viktor Roschke Ph.D Co-Founder
To view D&D Pharmatech’s complete executive team members history, request access »

D&D Pharmatech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator Minority 000 0000 000000 0
Geon Investment Venture Capital Minority 000 0000 000000 0
InterVest Venture Capital Minority 000 0000 000000 0
LB Investment Venture Capital Minority 000 0000 000000 0
Magna Investment Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

D&D Pharmatech Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 18-Jul-2018 00000 00000 00 0000 Drug Discovery 000000 0000000 00.0
To view D&D Pharmatech’s complete investments history, request access »

D&D Pharmatech Subsidiaries (1)

Company Name Industry Location Founded
0000000 Drug Discovery Gaithersburg, MD 0000
To view D&D Pharmatech’s complete subsidiaries history, request access »